Sodium-glucose cotransporter-2 inhibitor in risk of sepsis/septic shock among patients with type 2 diabetes mellitus—a retrospective analysis of nationwide medical claims data.

MLA

Hu, Wei-Syun, and Cheng-Li Lin. “Sodium-Glucose Cotransporter-2 Inhibitor in Risk of Sepsis/Septic Shock among Patients with Type 2 Diabetes Mellitus—a Retrospective Analysis of Nationwide Medical Claims Data.” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 397, no. 3, Mar. 2024, pp. 1623–31. EBSCOhost, https://doi.org/10.1007/s00210-023-02685-1.

APA

Hu, W.-S., & Lin, C.-L. (2024). Sodium-glucose cotransporter-2 inhibitor in risk of sepsis/septic shock among patients with type 2 diabetes mellitus—a retrospective analysis of nationwide medical claims data. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(3), 1623–1631. https://doi.org/10.1007/s00210-023-02685-1

Chicago

Hu, Wei-Syun, and Cheng-Li Lin. 2024. “Sodium-Glucose Cotransporter-2 Inhibitor in Risk of Sepsis/Septic Shock among Patients with Type 2 Diabetes Mellitus—a Retrospective Analysis of Nationwide Medical Claims Data.” Naunyn-Schmiedeberg’s Archives of Pharmacology 397 (3): 1623–31. doi:10.1007/s00210-023-02685-1.